全球首创！中国如何定义泛癌早筛新标准？| 只需一项检测，就能在肿瘤发生的最早阶段捕捉到危险信号。这不仅是一项技术突破，更是千万家庭的健康护盾。本期，LICC带你走进@华瑞同康 ：· 技术突破：专有的抗体工程技术具有极高的特异性与低干扰性。· 早筛价值：让癌症真正实现“找得早、测得准、更普惠”。· 医保赋能：基于TK1的风险预警与风险量化能力，推动健康管理与商业保险的深度融合，为重大疾病保险产品提供科学的数据基础。早筛人人可及不再是遥远的愿景，而是正在发生的生命守护。With a single test, signals can be caught at the earliest stage of tumor development. This is more than just a technological breakthrough. It’s a shield for millions of families.· Technological Breakthrough: A special antibody engineering technology with extremely high specificity and low interference.· Early Screening Value: Making it possible to detect cancer earlier, more accurately, and make screening more accessible.· Insurance Empowerment: Leveraging TK1’s risk warning and quantitative assessment to integrate health management with insurance, supporting the development of critical illness products.Early screening for everyone is no longer a distant vision. It is a life-changing reality.#WorldTop在龙华 #LICC #华瑞同康 #SSTK #癌症早筛 #TK1 #生物科技 #科技惠民 #EarlyCancerDetection #Biotech #HealthcareInnovation